137 results about "Drug usage" patented technology

A system and method for accurately and reliably determining and recording the time, date and location where a medication is used, and a system and method for transmitting, collecting, and using that data to improve clinical care, disease management, and public health surveillance. The device allows information concerning drug usage, including the time, date and location of use, to be transmitted to a remote network computer system so that the data can be evaluated to determine current impairment and future risk, and to identify changes in the frequency, timing, or location of medication usage indicative of change in disease control or management, and to examine spatial, temporal or demographic patterns of medication use or absence of use among individuals and groups. In addition, the device may further be configured to transmit signals indicative of its status, condition or other results to the remote network computer system.

A smart cap for a medical container for the containment of solid medications having unique indicia. The cap is provided with an optical scanner configured with at least one locally contained or external data base having general medication identification data and optionally patient-specific information to scan and identify the medication (and optionally the dosage, specific formulations, manufacturing source, etc.) and to record and correlate information regarding patient medication usage (scanning of a medication is generally considered indicative of actual patient taking of the medication). The cap further comprises communication elements configured to transmit / receive “usage” through scanning of a unit dosage of the medication, to an external data base such as the patient's cell phone and or computer (such as with blue tooth or RF communication) or via a telephone call or internet transmission to a data base of a pharmacy or physician or other health care provider.

A system links a standardized coded diagnosis associated with a medication order with information in a pharmacy information system to supplement medication utilization data. A pharmacy user interface system includes a user interface processor for providing data representing at least one display image supporting user entry of a coded diagnosis identifier for association with an order identifier identifying a medication order record indicating an order for a particular medication to be administered to a particular patient during an inpatient stay in a medical facility. A repository stores information associating multiple order identifiers and associated multiple coded diagnosis identifiers A utilization processor uses the stored repository information and processing data associating multiple order identifiers and associated multiple coded diagnosis identifiers to determine utilization information indicating usage characteristics of a particular medication for treatment of a condition indicated by a particular coded diagnosis.

An advertising method comprising having one or more advertisement messages for placing on a medication reminder card; and forming the medication reminder card to create visible means for advertising the one or more messages and reinforcing medication usage compliance. The advertisement messages are any message capable of being visibly placed upon the medication reminder card. The medication reminder card formed to create visible means for advertising the one or more messages reinforces medication usage compliance through one or more visible means.

The invention belongs to the field of drug analysis and particularly relates to a method of establishing a fingerprint spectrum of an infant diarrhea stopping drug preparation. According to the method, by taking the infant diarrhea stopping drug preparation as a detection object, the method of establishing the fingerprint spectrum of the infant diarrhea stopping drug preparation is established, common characteristic peaks including peak 1, peak 2 liquiritin, peak 3 ammonium glycyrrhizinate, peak 4, peak 5, peak 6, peak 7 and peak 8 are affirmed, the peak 2 liquiritin is selected as an internal reference peak in the fingerprint spectrum, and a relative retention time of each common characteristic peak is determined; and in addition, with combination of information of a plurality of chromatographic peaks in the fingerprint spectrum, the quality of the infant diarrhea stopping drug preparation can be comprehensively and rapidly detected, so that comprehensive quality detection and whole quality control of the infant diarrhea stopping drug preparation are facilitated, and improvement on the use safety and stability of the drug is facilitated. Simultaneously, the method of establishing the fingerprint spectrum of the infant diarrhea stopping drug preparation has the advantages of high precision, good repeatability, high stability and the like.

A patient care management system for assisting a physician in monitoring drug use by a patient. The system receives drug dispensation data for a drug, on the basis of which the system determines drug supply availability data. The drug supply availability data is indicative of periods of time during which the drug was available in non-duplicate supply, or in oversupply, or in insufficient supply. The periods of time are displayed with respect to a common time base. Each degree of supply availability is visually displayed via a graphical user interface using, e.g., a color coded scheme, so as to be distinguishable by a user. This allows a physician to rapidly assess over-consumption or compliance problems. Plural drugs may be monitored on a single display screen. The system may also be adapted to allow an prescribing physician to assess refill compliance, hospitalization periods and prescription drug costs.

In one aspect the invention provides an adherence monitoring device for a medication delivery device, the monitoring device including at least one inductive coil sensor which includes at least one inductive controller, at least two inductive coils including a first inductive coil coupled to the housing and a second inductive coil coupled to the housing. The first inductive coil is configured to exhibit a response to an inductive change and provide a first change signal in response to an inductive change, and the second inductive coil is configured to exhibit a response to the inductive change and provide a second change signal in response to the inductive change. The monitoring device also includes a processor configured to receive sensor data from the inductive controller representative of the first and second change signals provided by the first inductive coil and second inductive coil and to compare at least one characteristic of the first change signal and the second change signal to detect the occurrence of a medication usage event or a false triggering event.

The invention provides a drug for treating insomnia and dreaminess, and the drug comprises codonopsis pilosula, rhizoma corydalis, radix ophiopogonis, dens draconis, polygala root, cortex albiziae and caulis polygoni multiflori. The beneficial effects of the drug are that: due to use of the drug of the technical scheme, the insomnia and dreaminess can be radically treated, and the drug has the advantages of being convenient to use, obvious in effect, short in taking period, free of side effect and high in security.

The present invention relates to the treatment of disorders using anti-progestational agents. More specifically, the present invention relates to the treatment of disorders using low doses of anti-progestational agents. Compared to dosages and lengths of treatment taught by the prior art, the described methods, dosing regimens and medications use effective dosages and lengths of treatment that are lower and / or shorter than previously thought possible.

The invention discloses a method, device and system applied to a drug box for providing drug information for a user. By the adoption of the method, double drug-taking prompts can be provided for the user, not only can the user be reminded of the conditions of drug usage through voice, but also the amount of drugs taken by the user can be displayed through a display device, so that it is ensured that the user can receive prompt information accurately, the situations can not occur that the drugs are taken wrongly or taken in delay time, the health of the user is ensured, at the same time, a son or a daughter can preset setting information and the prompt information through external equipment, the supervision function is achieved, and the situation can be further ensured that the user takes the drugs correctly.

The invention provides methods for diagnosing, assessing or quantitating drug use, drug abuse or narcosis or for differentiating drug use, drug abuse or narcosis from brain injury in a subject by tracking eye movement of at least one eye of the subject, analyzing eye movement of at least one eye of the subject, comparing eye movement of at least one eye of the subject the normal or mean eye movement; and, optionally calculating a standard deviation or p value for eye movement of at least one eye of the subject as compared to the normal or mean eye movement.